These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34256833)

  • 1. Scintigraphic tracking of
    Beerts C; Brondeel C; Pauwelyn G; Depuydt E; Tack L; Duchateau L; Xu Y; Saunders JH; Peremans K; Spaas JH
    Stem Cell Res Ther; 2021 Jul; 12(1):393. PubMed ID: 34256833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homing of radiolabelled xenogeneic equine peripheral blood-derived MSCs towards a joint lesion in a dog.
    Beerts C; Pauwelyn G; Depuydt E; Xu Y; Saunders JH; Peremans K; Spaas JH
    Front Vet Sci; 2022; 9():1035175. PubMed ID: 36504848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scintigraphic tracking of mesenchymal stem cells after portal, systemic intravenous and splenic administration in healthy beagle dogs.
    Spriet M; Hunt GB; Walker NJ; Borjesson DL
    Vet Radiol Ultrasound; 2015; 56(3):327-34. PubMed ID: 25582730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scintigraphic comparison of intra-arterial injection and distal intravenous regional limb perfusion for administration of mesenchymal stem cells to the equine foot.
    Trela JM; Spriet M; Padgett KA; Galuppo LD; Vaughan B; Vidal MA
    Equine Vet J; 2014 Jul; 46(4):479-83. PubMed ID: 23834199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.
    Sole A; Spriet M; Padgett KA; Vaughan B; Galuppo LD; Borjesson DL; Wisner ER; Vidal MA
    Equine Vet J; 2013 Nov; 45(6):726-31. PubMed ID: 23574488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of canine leucocytes labelled with technetium-99m stannous fluoride colloid in whole blood and their ability to localise to sites of induced inflammation.
    Abushhiwa MH; Salehi NS; Lichtenstein M; Lording PM; Finnin PJ; Whitton RC; Charles JA; Parry BW
    Vet J; 2010 Aug; 185(2):157-62. PubMed ID: 19560377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99m) Tc-HMPAO.
    Sole A; Spriet M; Galuppo LD; Padgett KA; Borjesson DL; Wisner ER; Brosnan RJ; Vidal MA
    Equine Vet J; 2012 Sep; 44(5):594-9. PubMed ID: 22212017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous technetium-99m labelled PEG-liposomes in horses: a safety and biodistribution study.
    Underwood C; van Eps AW; Ross MW; Laverman P; van Bloois L; Storm G; Schaer TP
    Equine Vet J; 2012 Mar; 44(2):196-202. PubMed ID: 21696436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraarticular and intravenous administration of
    Meseguer-Olmo L; Montellano AJ; Martínez T; Martínez CM; Revilla-Nuin B; Roldán M; Mora CF; López-Lucas MD; Fuente T
    Nucl Med Biol; 2017 Mar; 46():36-42. PubMed ID: 28013120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
    Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
    Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.
    Barberini DJ; Aleman M; Aristizabal F; Spriet M; Clark KC; Walker NJ; Galuppo LD; Amorim RM; Woolard KD; Borjesson DL
    Stem Cell Res Ther; 2018 Apr; 9(1):96. PubMed ID: 29631634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunomodulatory properties of equine peripheral blood-derived mesenchymal stem cells in healthy cats.
    Debosschere Y; Depuydt E; Pauwelyn G; Beerts C; Van Hecke L; Verhaert L; Duchateau L; Saunders J; Tack L; Spaas JH
    Vet Immunol Immunopathol; 2020 Sep; 227():110083. PubMed ID: 32563854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of injected technetium(99m)-labeled mesenchymal stem cells in horses with naturally occurring tendinopathy.
    Becerra P; Valdés Vázquez MA; Dudhia J; Fiske-Jackson AR; Neves F; Hartman NG; Smith RK
    J Orthop Res; 2013 Jul; 31(7):1096-102. PubMed ID: 23508674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.
    Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH
    Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic tracking of mesenchymal stem cells after intravenous regional limb perfusion and subcutaneous administration in the standing horse.
    Spriet M; Buerchler S; Trela JM; Hembrooke TA; Padgett KA; Rick MC; Vidal MA; Galuppo LD
    Vet Surg; 2015 Apr; 44(3):273-80. PubMed ID: 25307554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-guided injection of the cranial tibial artery for stem cell administration in horses.
    Torrent A; Spriet M; Espinosa-Mur P; Clark KC; Whitcomb MB; Borjesson DL; Galuppo LD
    Equine Vet J; 2019 Sep; 51(5):681-687. PubMed ID: 30623489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
    Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
    Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous application of allogenic peripheral blood-derived mesenchymal stem cells: a safety assessment in 291 equine recipients.
    Broeckx S; Borena BM; Zimmerman M; Mariën T; Seys B; Suls M; Duchateau L; Spaas JH
    Curr Stem Cell Res Ther; 2014; 9(6):452-7. PubMed ID: 24548143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study.
    Broeckx SY; Spaas JH; Chiers K; Duchateau L; Van Hecke L; Van Brantegem L; Dumoulin M; Martens AM; Pille F
    Res Vet Sci; 2018 Apr; 117():246-254. PubMed ID: 29329028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions--a pilot study.
    Geburek F; Mundle K; Conrad S; Hellige M; Walliser U; van Schie HT; van Weeren R; Skutella T; Stadler PM
    Stem Cell Res Ther; 2016 Feb; 7():21. PubMed ID: 26830812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.